Down-regulation of SIRT1 was shown to mediate the reduction in PGC-1α activity and consequent mitochondrial dysfunction in a model of glycogen storage disease 1a deficient in G6Pase-a, a progressive liver disease that can result in hepatocellular adenoma and hepatocellular carcinoma [120]. This evidence concerns the gene SIRT1 and hepatocellular carcinoma.